Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

This is good for Obamacare: DC Circuit court will review Halbig

A major ruling against Obamacare is getting a second look.

The Appeals Court for the District of Columbia announced Thursday that it would re-hear Halbig v. Burwell en banc, meaning the entire panel of 11 judges will weigh in on the case. There will also be two senior judges who hear the case, but do not vote.

The D.C. Circuit Court previously ruled against the Affordable Care Act in its initial Halbig decision. It found that Obamacare subsidies were illegal in the 36 states where the federal government was running the health insurance exchange.

The en banc review has potential to be a big win for Obamacare because it opens up the possibility of the DC Circuit Court reversing its decision. The Fourth Circuit already ruled for Obamacare in a separate, Halbig-like case. If the en banc DC Circuit ruling also rules for the government, that would bring the two appellate courts into agreement on the subsidies’ legality.

And that could lessen the chances of this particular issue ever reaching the Supreme Court, which typically likes to opine on issues where there is a split in circuit opinions.

We don’t fully know how the en banc review will go for Obamacare, but the political make up of the panel does suggest a potentially friendlier venue for the law than the initial hearing.

You can read more about the original Halbig decision here (or a shorter, three sentence summary here).

More in Health Care

The End of HIV
The 45-year fight against HIV is one of humanity’s greatest victories. It’s also in danger.The 45-year fight against HIV is one of humanity’s greatest victories. It’s also in danger.
The End of HIV

We have the tools to end the virus. The question is whether we’ll abandon them.

By Bryan Walsh
The Highlight
The elder care solution that everyone with aging parents should know aboutThe elder care solution that everyone with aging parents should know about
The Highlight

As baby boomers age, caregivers are often squeezed caring for parents and children at the same time. They need help.

By Courtney E. Martin
Good Medicine
The cocaine comeback, explainedThe cocaine comeback, explained
Good Medicine

The next phase of America’s drug crisis is here.

By Dylan Scott
Future Perfect
The world’s deadliest infectious disease is on the rise in the USThe world’s deadliest infectious disease is on the rise in the US
Future Perfect

We discovered its cause 144 years ago. It’s still a massive problem.

By Shayna Korol
Good Medicine
How to talk to your doctor about moneyHow to talk to your doctor about money
Good Medicine

Health care in America is too expensive. But you can make your physician your ally.

By Dylan Scott
Good Medicine
Nurse practitioners are rushing in to fill the gaps in US health careNurse practitioners are rushing in to fill the gaps in US health care
Good Medicine

You need a primary care appointment. Should you see an MD — or NP?

By Dylan Scott